Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A scoping review on the current state of sex- and gender-based analysis (SGBA) in standing balance research.
Gait Posture
March 2025
College of Kinesiology, University of Saskatchewan, SK, Canada. Electronic address:
Background: Understanding sex and gender differences in standing balance is challenged by varied use of terminology and definitions. In addition, the use of sex- and gender-based analyses (SGBA) in standing balance research is unknown. This scoping review examined the frequency and type of SGBA, and the use of sex- and gender-based terminology in standing balance research published in the year 2020.
View Article and Find Full Text PDFCardiotoxicity of breast cancer drug treatments.
Transl Oncol
March 2025
School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences University of Nottingham, UK; Biodiscovery Institute, Faculty of Medicine and Health Sciences, University of Nottingham, UK. Electronic address:
Breast cancer (BC) is a leading cause of cancer-related mortality among women worldwide. BC is regarded as a systemic disease. Consequently, the majority of BC patients undergo systemic therapy to reduce the risk of distant metastasis (DM) and associated mortality.
View Article and Find Full Text PDFCrizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial.
Lancet Haematol
March 2025
University of Ghana Medical School, Korle Bu Teaching Hospital, Accra, Ghana.
Background: Crizanlizumab has previously shown efficacy as a potent disease-modifying therapy for alleviating vaso-occlusive crisis in sickle cell disease. The SUSTAIN study showed a reduction of vaso-occlusive crises in patients treated with 5 mg/kg crizanlizumab, compared with placebo. The STAND study aimed to evaluate the efficacy and safety of two doses (5·0 mg/kg and 7·5 mg/kg) of crizanlizumab in sickle cell disease.
View Article and Find Full Text PDFMedBin: A lightweight End-to-End model-based method for medical waste management.
Waste Manag
March 2025
Department of Mechanical Engineering, School of Engineering, University of Birmingham, Birmingham B15 2TT, UK. Electronic address:
The surge in medical waste has highlighted the urgent need for cost-effective and advanced management solutions. In this paper, a novel medical waste management approach, "MedBin," is proposed for automated sorting, reusing, and recycling. A comprehensive medical waste dataset, "MedBin-Dataset" is established, comprising 2,119 original images spanning 36 categories, with samples captured in various backgrounds.
View Article and Find Full Text PDFNano biosensor unlocks tumor derived immune signals for the early detection of ovarian cancer.
Biosens Bioelectron
March 2025
Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership Between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada; Ultrashort Laser Nanomanufacturing Research Facility, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, ON, M5B 2K3, Canada; Nano-Bio Interface Facility, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, ON, M5B 2K3, Canada; Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, Ontario, M5B 1W8, Canada. Electronic address:
Ovarian cancer is a critical health issue for women nowadays. Its impact is significant because of its high mortality rate (324,603 worldwide), late-stage diagnosis and poor survival rate. Lack of screening tests, vague symptoms, misdiagnosis, and age factor makes it even more difficult to detect.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!